Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Mon, 22.05.2023
SHOP APOTHEKE EUROPE N.V.
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig [ … ]
Thu, 11.05.2023
SHOP APOTHEKE EUROPE N.V.
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today.
In late March 2023, SHOP APOTHEKE EUROPE, Europe’s [ … ]
Thu, 11.05.2023
SHOP APOTHEKE EUROPE N.V.
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today.
In late March 2023, SHOP APOTHEKE EUROPE, Europe’s [ … ]
Thu, 11.05.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma [ … ]
Thu, 11.05.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma [ … ]
Tue, 02.05.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
Total sales up 22% to EUR 372 million.
Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%.
Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%.
Comfortably on tra [ … ]
Tue, 02.05.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
Total sales up 22% to EUR 372 million.
Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%.
Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%.
Comfortably on tra [ … ]
Thu, 27.04.2023
SHOP APOTHEKE EUROPE N.V.
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich [ … ]
Thu, 27.04.2023
SHOP APOTHEKE EUROPE N.V.
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich [ … ]
Wed, 05.04.2023
SHOP APOTHEKE EUROPE N.V.
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
Q1 total sales up 22% year over year to EUR 371 million.
Non-Rx sales growth 23%.
Customer satisfaction remains very high with NPS above 70.
Continued fast growth of customer base to 9.7 million; active customer base up 0.4 million in Q1 and 1.4 million year over [ … ]